Robust cell assays for global clinical trials
13 Feb 2025

Thomas (TJ) Beadnell, Scientific Advisor at Eurofins Clinical Trial Solutions, explores key considerations for developing live cell assays to support global clinical trials. He discusses strategies for optimizing assay logistics, ensuring antigen stability, and selecting the right matrix and collection methods to maintain sample integrity. By addressing logistical challenges and best practices in assay development, this video provides valuable insights into building robust, reliable assays that drive successful clinical outcomes. Download the free handout for further detail.
About the company
Eurofins Clinical Trial Solutions
Complex innovative clinical trial designs require an integrated synergetic approach to assess novel drug compounds for safety and effectiveness which often span esoteric, regulated and safety outcomes in all phases of the drug development life cycle. The companies of Eurofins Bioanalytical Services, the Eurofins Central Laboratory global network, Eurofins Viracor BioPharma Services, and Eurofins Clinical Trial Supplies are building a stronger connection to provide a seamless solutions-based approach to our client needs. Eurofins Clinical Trial Solutions provides seamless, end-to-end solutions to help clients progress through the drug development cycle through a single, experienced provider. Our integrated solutions deliver the most comprehensive range of state-of-the-art analytical technologies with an expansive geographic reach in order to support our clients’ specialized testing needs and stringent quality and safety requirements around the world.

